Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer.

Ther Adv Med Oncol · 2023 · PMC10486227 · PMID 37692364

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Specifically, patients with bladder cancer with TMB-high showed a trend for higher ICI response rates (38% versus 15%) and for a better prognosis. 33 UC is a highly complex tumor with a median mutation number of 9.6 mut/Mb.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.